SA
Sign upLog In

Ani Pharmaceuticals Inc (ANIP)

R&D Expenses

$49.91M

TTM · Period ending: · USD

ANIP logo

ANIP R&D Expenses

Latest reported$49.91M
ANIP TTM R&D Expenses ($1.89M → $49.91M)
High-resolution chart · PNG

ANIP r&d expenses history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Ani Pharmaceuticals Inc R&D Expenses — Trailing twelve months (TTM) (USD)
Period endingR&D Expenses (USD)
49,912,000
51,700,000
51,664,000
56,049,000
53,873,000
44,634,000
44,581,000
37,802,000
38,795,000
38,873,000
34,286,000
29,641,000
26,177,000
22,968,000
22,318,000
20,236,000
15,035,000
13,675,000
11,369,000
11,912,000
12,395,000
12,625,000
16,001,000
16,996,000
19,039,000
21,777,000
19,806,000
18,610,000
18,295,000
17,659,000
15,388,000
14,557,000
12,524,000
9,554,000
9,070,000
6,554,000
4,961,000
3,558,000
2,906,000
3,432,000
3,206,000
3,437,000
2,874,000
2,781,000
2,849,000
2,705,000
2,678,000
2,634,000
2,204,897
1,791,081
2,387,130
4,297,721
7,716,560
12,677,681
16,888,849
21,155,645
28,782,962
34,500,980
44,182,183
49,385,731
47,601,769
45,143,052
39,705,502
31,544,107
25,199,233
20,035,203
13,680,573
13,792,477
15,743,732
16,184,274
15,789,980
13,146,768
8,970,060
6,383,303
4,619,209
4,362,580
3,983,408
3,750,635
3,855,660
3,915,285
4,462,976
5,276,278
6,409,080
8,783,533
9,919,736
9,857,595
9,162,439
6,761,696
5,271,415
4,344,790
3,691,420
4,530,822
4,897,173
4,945,577
4,786,818
3,761,065
3,153,641
2,553,349
2,141,944
1,632,427
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.